Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384397886> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W4384397886 endingPage "216" @default.
- W4384397886 startingPage "215" @default.
- W4384397886 abstract "Dear Editor, we would like to share ideas on the publication Reactogenicity Study of mRNA Vaccines Against COVID-19. Inglés Torruella et al. compare the reactogenicity of two types of mRNA vaccines against COVID-19, Commirnaty® (Pfizer) and Spikevax® (Moderna), in a healthcare population. According to Inglés Torruella et al., the greater reactogenicity and its consequences for the first and second doses of the Spikevax® vaccine compared to Comirnaty®, and for the second dose compared to the first dose of both vaccines, provides useful knowledge for planning COVID-19 vaccination campaigns in healthcare settings. A variety of factors need to be looked at in order to fully understand the results. It is impossible to draw a relationship between asymptomatic COVID-19 and the lack of symptoms without the required laboratory investigations. Without extensive laboratory testing, asymptomatic COVID-19 and the lack of clinical symptoms could be incorrectly diagnosed. A silent COVID-19 must be ruled out if neither the most recent clinical signals nor the most recent clinical markers are present. Additionally, genetic variations appear to affect how certain individuals' immune systems react to COVID-19. Before the findings can be verified, more clinical study will be needed.Estimada Editora, nos gustaría compartir ideas sobre la publicación Reactogenicity Study of mRNA Vaccines Against COVID-19. Inglés Torruella et al. comparan la reactogenicidad de dos tipos de vacunas de ARNm frente a COVID-19, Commirnaty® (Pfizer) y Spikevax® (Moderna), en una población sanitaria. Según Inglés Torruella et al., la mayor reactogenicidad y sus consecuencias para la primera y segunda dosis de la vacuna Spikevax® en comparación con Comirnaty®, y para la segunda dosis en comparación con la primera dosis de ambas vacunas, proporciona un conocimiento útil para la planificación de campañas de vacunación frente a COVID-19 en entornos sanitarios. Para comprender plenamente los resultados es necesario tener en cuenta diversos factores. Es imposible establecer una relación entre la COVID-19 asintomática y la ausencia de síntomas sin las necesarias investigaciones de laboratorio necesarias. Sin pruebas de laboratorio exhaustivas, la COVID-19 asintomática y la ausencia de síntomas clínicos podrían diagnosticarse incorrectamente. Debe descartarse una COVID-19 silente si no están presentes ni las señales clínicas más recientes ni los marcadores clínicos más recientes. Además, las variaciones genéticas parecen afectar a la forma en que el sistema inmunitario de determinados individuos reacciona a la COVID-19. Antes de que puedan verificarse los hallazgos, serán necesarios más estudios clínicos." @default.
- W4384397886 created "2023-07-16" @default.
- W4384397886 creator A5046944381 @default.
- W4384397886 creator A5081907229 @default.
- W4384397886 date "2023-07-14" @default.
- W4384397886 modified "2023-10-17" @default.
- W4384397886 title "Comment on Reactogenicity Study of mRNA COVID-19 Vaccine" @default.
- W4384397886 doi "https://doi.org/10.12961/aprl.2023.26.03.04" @default.
- W4384397886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37485944" @default.
- W4384397886 hasPublicationYear "2023" @default.
- W4384397886 type Work @default.
- W4384397886 citedByCount "0" @default.
- W4384397886 crossrefType "journal-article" @default.
- W4384397886 hasAuthorship W4384397886A5046944381 @default.
- W4384397886 hasAuthorship W4384397886A5081907229 @default.
- W4384397886 hasBestOaLocation W43843978861 @default.
- W4384397886 hasConcept C126322002 @default.
- W4384397886 hasConcept C159047783 @default.
- W4384397886 hasConcept C203014093 @default.
- W4384397886 hasConcept C22070199 @default.
- W4384397886 hasConcept C2777704310 @default.
- W4384397886 hasConcept C2777910003 @default.
- W4384397886 hasConcept C2779134260 @default.
- W4384397886 hasConcept C2780868878 @default.
- W4384397886 hasConcept C2908647359 @default.
- W4384397886 hasConcept C3008058167 @default.
- W4384397886 hasConcept C524204448 @default.
- W4384397886 hasConcept C71924100 @default.
- W4384397886 hasConcept C8891405 @default.
- W4384397886 hasConcept C99454951 @default.
- W4384397886 hasConceptScore W4384397886C126322002 @default.
- W4384397886 hasConceptScore W4384397886C159047783 @default.
- W4384397886 hasConceptScore W4384397886C203014093 @default.
- W4384397886 hasConceptScore W4384397886C22070199 @default.
- W4384397886 hasConceptScore W4384397886C2777704310 @default.
- W4384397886 hasConceptScore W4384397886C2777910003 @default.
- W4384397886 hasConceptScore W4384397886C2779134260 @default.
- W4384397886 hasConceptScore W4384397886C2780868878 @default.
- W4384397886 hasConceptScore W4384397886C2908647359 @default.
- W4384397886 hasConceptScore W4384397886C3008058167 @default.
- W4384397886 hasConceptScore W4384397886C524204448 @default.
- W4384397886 hasConceptScore W4384397886C71924100 @default.
- W4384397886 hasConceptScore W4384397886C8891405 @default.
- W4384397886 hasConceptScore W4384397886C99454951 @default.
- W4384397886 hasIssue "3" @default.
- W4384397886 hasLocation W43843978861 @default.
- W4384397886 hasLocation W43843978862 @default.
- W4384397886 hasOpenAccess W4384397886 @default.
- W4384397886 hasPrimaryLocation W43843978861 @default.
- W4384397886 hasRelatedWork W2120009422 @default.
- W4384397886 hasRelatedWork W2408404678 @default.
- W4384397886 hasRelatedWork W2408866016 @default.
- W4384397886 hasRelatedWork W2408949225 @default.
- W4384397886 hasRelatedWork W2409856128 @default.
- W4384397886 hasRelatedWork W2805532471 @default.
- W4384397886 hasRelatedWork W3151384479 @default.
- W4384397886 hasRelatedWork W3177694513 @default.
- W4384397886 hasRelatedWork W4200080357 @default.
- W4384397886 hasRelatedWork W4290258953 @default.
- W4384397886 hasVolume "26" @default.
- W4384397886 isParatext "false" @default.
- W4384397886 isRetracted "false" @default.
- W4384397886 workType "article" @default.